Appeal No. 2005-0545
Application No. 09/989,019
treatment of obesity, accummulation of fat, localized accumulation
of fat, cellulite or associated cellulitis. Each of the prior art
agents is said to be active for promoting fat degradation and/or
lean body mass, controlling digestion and absorption of lipids,
increasing lipolysis, inhibiting phosphodiesterase activity,
slimming, treating obesity, treating cellulite, treating cellulitis
or regenerating tissue. Thus, it also would have been obvious to
make and use the multicomponent compositions Pugliese claims for any
of the reasons the applied prior art suggests with reasonable
expectation that the compositions would generally promote fat
degradation and/or lean body mass, control digestion and absorption
of lipids, increase lipolysis, inhibit phosphodiesterase activity,
promote slimming, treat obesity or regenerate tissue. Persons
having ordinary skill in the art reasonably would have expected that
compositions comprising all the active agents described by the
applied prior art would promote fat degradation and/or lean body
mass, control digestion and absorption of lipids, increase
lipolysis, inhibit phosphodiesterase activity, cause slimming, treat
obesity and regenerate tissue associated with cellulite and
associated cellulitis.
Most of the cited references explicitly state that the agents
described are thought to be active for treating localized
14
Page: Previous 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
Last modified: November 3, 2007